SCHEMBL25920215

SCHEMBL25920215

CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)c(N3CCC(=O)NC3=O)c1)CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.48
▸ HIF1A Q16665 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ CRBN Q96SW2 2/20 0.41
▸ GABRD O14764 2/20 0.40
▸ GABRA1 P14867 2/20 0.40
▸ GABRB1 P18505 2/20 0.40
▸ GABRA5 P31644 2/20 0.40
▸ GABRA3 P34903 2/20 0.40
▸ GABRA2 P47869 2/20 0.40
▸ GABRB2 P47870 2/20 0.40
▸ GABRA4 P48169 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ AR P10275 2/20 0.39
▸ ENPP2 Q13822 1/20 0.39
▸ ATXN2 Q99700 1/20 0.39
▸ JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30014819 0.90 HPGD (0.43) ALDH1A1GABRDGABRA1GABRB1GABRA5
SCHEMBL25596266 0.89 GABRD (0.51) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL30014379 0.89 GABRD (0.51) GABRDGABRA1GABRB1GABRA5GABRA3
Hydrochloric Acid SCHEMBL30864123 0.88 GABRD (0.50) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL26100334 0.88 NAMPT (0.41) CRBNGABRDGABRA1GABRB1GABRA5
SCHEMBL30267288 0.88 GABRD (0.41) CRBNGABRDGABRA1GABRB1GABRA5
SCHEMBL25920183 0.86 L3MBTL3 (0.43) CRBNGABRDGABRA1GABRB1GABRA5
SCHEMBL26509089 0.86 MEN1 (0.46) ALDH1A1CRBNKMT2ACYP1A2POLB
SCHEMBL25920200 0.86 MGLL (0.38) MAPK1CRBNGABRDGABRA1GABRB1
SCHEMBL25213849 0.85 CHRM2 (0.41) MAPK1HIF1AALDH1A1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4393922-A1 IRAK4 DEGRADATION AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-07-03 — — EP disclosed
US-20230234936-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD. (CN) 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234936-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF IRAK4, IRAK2, IRAK1 MAPK1 1118/4885HIF1A 2031/4885ALDH1A1 3835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback